 |
Click HERE for details on the Oligo Fund
Search Term: Oligodendroglioma Low Grade
Search results are returned below separately for clinical trials, frequently asked questions, pages on this site, and news articles - scroll down to see them all!
Trials and Noteworthy Treatments
 |
 |
 |
 |
|
 |
Treatment Next 25
|
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma |
 |
Cincinnati, OH Birmingham, AL Phoenix, AZ La Jolla, CA Orange, CA Denver, CO Norwich, CT Newark, DE Jacksonville, FL Atlanta, GA Des Moines, IA Chicago, IL Wichita, KS New Orleans, LA Baltimore, MD Kalamazoo, MI Charlotte, NC Lebanon, NH New Brunswick, NJ Syracuse, NY Cleveland, OH Cleveland, OH Portland, OR Philadelphia, PA Spartanburg, SC Rapid City, SD Nashville, TN Dallas, TX Galveston, TX Houston, TX Saint George, UT Salt Lake City, UT Charlottesville, VA Richmond, VA Seattle, WA Green Bay, WI La Crosse, WI Madison, WI Milwaukee, WI |
 |
09/26/2012 |
 |
 |
 |
 |
 |
Details |
 |
A Phase 2 Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Tumors of the Brain |
 |
San Francisco, CA |
 |
04/05/2012 |
 |
 |
 |
Details |
 |
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
 |
Jacksonville, FL Ames, IA Cedar Rapids, IA Missouri Valley, IA Sioux City, IA Moline, IL Peoria, IL Urbana, IL Wichita, KS Lambertville, MI Duluth, MN Saint Louis Park, MN Billings, MT Bismarck, ND Lincoln, NE Allentown, PA Danville, PA Sayre, PA Spartanburg, SC Rapid City, SD Sioux Falls, SD |
 |
01/12/2010 |
 |
 |
 |
 |
 |
Details |
 |
A Phase I Trial and Pharmacokinetic Study of Trabectedin (Yondelis®, ET-743) in Children and Adolescents With Relapsed or Refractory Solid Tumors
|
 |
Bethesda, MD |
 |
04/22/2009 |
 |
 |
 |
Details |
 |
A Phase I/II Trial of ZD6474 for Patients With Recurrent High-Grade and Progressive Low-Grade Gliomas
|
 |
Bethesda, MD |
 |
04/22/2009 |
 |
 |
 |
 |
 |
Details |
 |
Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
|
 |
Bethesda, MD |
 |
04/22/2009 |
 |
 |
 |
Details |
 |
Phase II Trial of RAD001 in Patients with Recurrent Low Grade Glioma |
 |
San Francisco, CA |
 |
04/06/2009 |
 |
 |
 |
 |
 |
Details |
 |
Quality of Life in Patients with Brain Tumors, Skull Base Tumors & Pituitary Adenomas Undergoing Surgical Resection |
 |
Santa Monica, CA |
 |
11/29/2008 |
 |
 |
 |
Details |
 |
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
 |
Charlottesville, VA |
 |
09/30/2008 |
 |
 |
 |
 |
 |
Details |
 |
Gliogene: An International Brain Tumor Study |
 |
Houston, TX |
 |
07/24/2008 |
 |
 |
 |
Details |
 |
A Phase II Study of Temozolomide (temodar) in the Treatment of Adult Patients with
Supratentorial Low Grade Glioma |
 |
San Francisco, CA |
 |
10/03/2007 |
 |
 |
 |
 |
 |
Details |
 |
NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
|
 |
Los Angeles, CA Boston, MA Boston, MA New York, NY Pittsburgh, PA Houston, TX San Antonio, TX Madison, WI |
 |
10/03/2007 |
 |
 |
 |
Details |
 |
Brain Mapping for Brain Tumors |
 |
Boston, MA |
 |
08/18/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
 |
Phoenix, AZ New Haven, CT Lewes, DE Fort Lauderdale, FL Jacksonville, FL Jacksonville, FL Miami, FL Columbus, GA Dubuque, IA Detroit, MI Kalamazoo, MI Lambertville, MI Rochester, MN Rochester, MN Saint Louis Park, MN Springfield, MO Omaha, NB Goldsboro, NC Lebanon, NH Long Branch, NJ Mount Holly, NJ Albuquerque, NM Buffalo, NY Utica, NY , OH Akron, OH Cleveland, OH Tulsa, OK Portland, OR Philadelphia, PA Philadelphia, PA Wynnewood, PA Greenville, SC Kingsport, TN Salt Lake City, UT Madison, WI |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Phase II Randomized Study of Intra-Arterial Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Delayed High-Dose Sodium Thiosulfate in Patients With High-Grade Glioma |
 |
Cleveland, OH Columbus, OH Portland, OR |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
 |
Jacksonville, FL Jacksonville, FL Des Moines, IA Moline, IL Peoria, IL Urbana, IL Wichita, KS Lambertville, MI Rochester, MN Saint Louis Park, MN Billings, MT Bismarck, ND Lincoln, NE Danville, PA Spartanburg, SC Sioux Falls, SD |
 |
06/26/2006 |
 |
 |
 |
Details |
 |
Pilot Randomized Study of Modafinil for Treatment of Fatigue and Neurobehavioral Dysfunction in Patients With Primary Brain Tumors |
 |
Los Angeles, CA |
 |
05/29/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma |
 |
Toronto, Ontario, , Canada |
 |
05/21/2006 |
 |
 |
 |
Details |
 |
Phase II Study of Temozolomide in Patients With Supratentorial Low-Grade Glioma |
 |
San Francisco, CA |
 |
05/02/2006 |
 |
 |
 |
 |
 |
Details |
 |
Pharmacological intervention for learning impaired children surviving treatment for cancer. |
 |
Durham, NC |
 |
12/03/2005 |
 |
 |
 |
Details |
 |
Gamma Knife Radiosurgery for Brain Tumors |
 |
La Jolla, CA |
 |
12/03/2005 |
 |
 |
 |
 |
 |
Details |
 |
A Phase I dose escalation trial of Temodar that will attempt to determine the maximum tolerated dose of Temodar (Temozolomide) when given by prolonged oral exposure to children with recurrent or progressive brain tumors. |
 |
New York, NY |
 |
12/03/2005 |
 |
 |
 |
Details |
 |
Gamma Knife Radiosurgery |
 |
Edison, NJ |
 |
12/03/2005 |
 |
 |
 |
 |
 |
Details |
 |
Gamma knife stereotactic radiosurgery for benign and malignant brain tumors and brain metastases. |
 |
Rockville Centre, NY |
 |
12/03/2005 |
 |
 |
 |
Details |
 |
Quality of Life Studies (There are 19 seperate studies listed here) |
 |
Durham, NC |
 |
12/03/2005 |
 |
 |
 |
 |
 |
News Stories
Frequently Asked Questions
|
|